Adaptive Topical Compositions of Dutasteride for Specialized Environments

Publication ID: 24-11857556_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Topical Compositions of Dutasteride for Specialized Environments,” Published Technical Disclosure No. 24-11857556_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857556_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,556.

Summary of the Inventive Concept

The present inventive concept relates to specialized topical compositions of dutasteride adapted for unique operational environments, including extreme weather conditions, high-altitude environments, sensitive skin, disaster relief, and high-security needs.

Background and Problem Solved

The original patent disclosed topical compositions of dutasteride for preventing hair loss and stimulating hair growth. However, these compositions may not be suitable for specific environments or populations, such as extreme weather conditions, high-altitude environments, or individuals with sensitive skin. The present inventive concept addresses these limitations by providing adaptive topical compositions of dutasteride that cater to these niche requirements.

Detailed Description of the Inventive Concept

The inventive concept encompasses five specialized variations of topical compositions of dutasteride. Firstly, a composition formulated to withstand temperatures above 40°C and humidity above 80% for use in extreme weather conditions. Secondly, a method for preventing hair loss in high-altitude environments, where the composition is adapted to counteract the effects of low air pressure and low oxygen levels. Thirdly, a composition for stimulating hair growth in individuals with sensitive skin, incorporating a soothing agent selected from aloe vera, chamomile, and green tea. Fourthly, a kit for disaster relief, comprising a topical composition of dutasteride, a protective ointment, and a set of instructions for use in emergency situations. Lastly, a system for high-security needs, where the composition is formulated to be tamper-evident and to prevent unauthorized access.

Novelty and Inventive Step

The inventive concept's novelty lies in its adaptation of dutasteride compositions for specific, niche environments and populations, which is not obvious from the original patent. The inventive step involves the development of specialized formulations and systems that address the unique challenges and requirements of these environments and populations.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include compositions adapted for use in space exploration, military operations, or other extreme environments. Variations of the kit for disaster relief could include additional components, such as a first-aid guide or a communication device.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including pharmaceuticals, cosmetics, and disaster relief. The target market includes individuals and organizations operating in extreme environments, as well as those requiring specialized hair care solutions for sensitive skin or high-security needs.

Field of Art

Pharmaceutical formulations, specifically topical compositions for hair loss treatment involving 5α-reductase inhibitors, requiring expertise in pharmaceutical chemistry, drug delivery systems, and dermatological formulation techniques

Person of Ordinary Skill (PHOSITA) Profile

A pharmaceutical formulation scientist with advanced degree (MS/PhD), experience in drug delivery, knowledge of excipients, understanding of topical composition design, and familiarity with hair loss treatment technologies

Obviousness Rationale

A PHOSITA would recognize that the specialized dutasteride compositions represent predictable variations of the source patent's core formulation by applying standard pharmaceutical engineering techniques. The fundamental composition remains consistent, with modifications addressing specific environmental or user requirements using known pharmaceutical strategies. These adaptations represent routine optimization within the established framework of the original topical dutasteride composition.

Obvious Combinations & Variations

Source Patent Element
Topical composition with specific dutasteride concentration and carrier oils
PTD Variation
Extreme weather formulation with temperature and humidity resistance
Obviousness Reasoning
Modifying excipient ratios and adding stabilizing agents to enhance environmental tolerance is a predictable design choice for pharmaceutical formulations
Source Patent Element
Base topical composition for hair growth stimulation
PTD Variation
Sensitive skin composition incorporating soothing botanical agents
Obviousness Reasoning
Adding known dermatological soothing agents to reduce skin irritation is a standard pharmaceutical approach for improving topical drug delivery
Source Patent Element
Dutasteride-based topical hair loss treatment
PTD Variation
High-altitude environment adaptation addressing pressure and oxygen variations
Obviousness Reasoning
Adjusting carrier composition to maintain drug efficacy under different physiological conditions represents standard pharmaceutical formulation optimization
Source Patent Element
Basic topical composition methodology
PTD Variation
Disaster relief kit with protective packaging and instructional components
Obviousness Reasoning
Creating application-specific packaging and usage instructions is a routine product development strategy in pharmaceutical delivery systems
Source Patent Element
Standard topical composition design
PTD Variation
High-security formulation with tamper-evident features
Obviousness Reasoning
Implementing security measures in pharmaceutical packaging is a known technique for preventing unauthorized access and ensuring product integrity
35 U.S.C. § 103 Summary: Based on US Patent 11857556's disclosure of topical dutasteride compositions, the present publication demonstrates that variations addressing specific environmental, physiological, and operational contexts would be obvious to a person having ordinary skill in pharmaceutical formulation. The disclosed adaptations represent predictable extensions of the source patent's fundamental composition, utilizing standard pharmaceutical engineering techniques to optimize drug delivery across diverse application scenarios.

Original Patent Information

Patent NumberUS 11,857,556
TitleTopical compositions of dutasteride
Assignee(s)SHILPA MEDICARE LIMITED